BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 12472776)

  • 1. A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats.
    Arumugam TV; Shiels IA; Strachan AJ; Abbenante G; Fairlie DP; Taylor SM
    Kidney Int; 2003 Jan; 63(1):134-42. PubMed ID: 12472776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of a new C5a receptor antagonist against ischemia-reperfusion injury in the rat small intestine.
    Arumugam TV; Shiels IA; Woodruff TM; Reid RC; Fairlie DP; Taylor SM
    J Surg Res; 2002 Apr; 103(2):260-7. PubMed ID: 11922743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of a potent C5a receptor antagonist on experimental acute limb ischemia-reperfusion in rats.
    Woodruff TM; Arumugam TV; Shiels IA; Reid RC; Fairlie DP; Taylor SM
    J Surg Res; 2004 Jan; 116(1):81-90. PubMed ID: 14732352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of a human C5a receptor antagonist against hepatic ischaemia-reperfusion injury in rats.
    Arumugam TV; Woodruff TM; Stocks SZ; Proctor LM; Pollitt S; Shiels IA; Reid RC; Fairlie DP; Taylor SM
    J Hepatol; 2004 Jun; 40(6):934-41. PubMed ID: 15158333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative anti-inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia/reperfusion injury.
    Proctor LM; Arumugam TV; Shiels I; Reid RC; Fairlie DP; Taylor SM
    Br J Pharmacol; 2004 Jun; 142(4):756-64. PubMed ID: 15159277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of immune-complex mediated dermal inflammation in rats following either oral or topical administration of a small molecule C5a receptor antagonist.
    Strachan AJ; Shiels IA; Reid RC; Fairlie DP; Taylor SM
    Br J Pharmacol; 2001 Dec; 134(8):1778-86. PubMed ID: 11739255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Montelukast protects against renal ischemia/reperfusion injury in rats.
    Sener G; Sehirli O; Velioğlu-Oğünç A; Cetinel S; Gedik N; Caner M; Sakarcan A; Yeğen BC
    Pharmacol Res; 2006 Jul; 54(1):65-71. PubMed ID: 16584888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement C5a receptor antagonist attenuates multiple organ injury in a model of ruptured abdominal aortic aneurysm.
    Harkin DW; Romaschin A; Taylor SM; Rubin BB; Lindsay TF
    J Vasc Surg; 2004 Jan; 39(1):196-206. PubMed ID: 14718840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protective effect of oxytocin on renal ischemia/reperfusion injury in rats.
    Tuğtepe H; Sener G; Biyikli NK; Yüksel M; Cetinel S; Gedik N; Yeğen BC
    Regul Pept; 2007 May; 140(3):101-8. PubMed ID: 17261335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cysteinyl leukotriene receptor antagonism alleviates renal injury induced by ischemia-reperfusion in rats.
    Hagar HH; Abd El Tawab R
    J Surg Res; 2012 Nov; 178(1):e25-34. PubMed ID: 22487384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of sensory neurons reduces ischemia/reperfusion-induced acute renal injury in rats.
    Mizutani A; Okajima K; Murakami K; Mizutani S; Kudo K; Uchino T; Kadoi Y; Noguchi T
    Anesthesiology; 2009 Feb; 110(2):361-9. PubMed ID: 19194162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenectomy ameliorates acute multiple organ damage induced by liver warm ischemia reperfusion in rats.
    Jiang H; Meng F; Li W; Tong L; Qiao H; Sun X
    Surgery; 2007 Jan; 141(1):32-40. PubMed ID: 17188165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginkgo biloba extract ameliorates ischemia reperfusion-induced renal injury in rats.
    Sener G; Sener E; Sehirli O; Oğünç AV; Cetinel S; Gedik N; Sakarcan A
    Pharmacol Res; 2005 Sep; 52(3):216-22. PubMed ID: 15896977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-lipoic acid protects against hepatic ischemia-reperfusion injury in rats.
    Dulundu E; Ozel Y; Topaloglu U; Sehirli O; Ercan F; Gedik N; Sener G
    Pharmacology; 2007; 79(3):163-70. PubMed ID: 17259747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation.
    De Vries B; Matthijsen RA; Wolfs TG; Van Bijnen AA; Heeringa P; Buurman WA
    Transplantation; 2003 Feb; 75(3):375-82. PubMed ID: 12589162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils.
    de Vries B; Köhl J; Leclercq WK; Wolfs TG; van Bijnen AA; Heeringa P; Buurman WA
    J Immunol; 2003 Apr; 170(7):3883-9. PubMed ID: 12646657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat.
    Chatterjee PK; Cuzzocrea S; Brown PA; Zacharowski K; Stewart KN; Mota-Filipe H; Thiemermann C
    Kidney Int; 2000 Aug; 58(2):658-73. PubMed ID: 10916089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephroprotective effect of telmisartan in rats with ischemia/reperfusion renal injury.
    Fouad AA; Qureshi HA; Al-Sultan AI; Yacoubi MT; Al-Melhim WN
    Pharmacology; 2010; 85(3):158-67. PubMed ID: 20150754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C5a/C5aR pathway accelerates renal ischemia-reperfusion injury by downregulating PGRN expression.
    Zhang K; Li GQ; He QH; Li Y; Tang M; Zheng QY; Xu GL; Zhang KQ
    Int Immunopharmacol; 2017 Dec; 53():17-23. PubMed ID: 29031143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A potent human C5a receptor antagonist protects against disease pathology in a rat model of inflammatory bowel disease.
    Woodruff TM; Arumugam TV; Shiels IA; Reid RC; Fairlie DP; Taylor SM
    J Immunol; 2003 Nov; 171(10):5514-20. PubMed ID: 14607958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.